Large Study Links GLP-1s to Lower Risk of Multiple Cancers
2026-06-09
MedPage Today) — Patients taking GLP-1 receptor agonists for obesity had a 41% lower risk of obesity-related cancers as compared with patients treated with diet or exercise, a large propensity-matched cohort study showed. After 2 years of follow…Read MoreContinue Reading